Stacey Stein

5.8k total citations
74 papers, 1.4k citations indexed

About

Stacey Stein is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Stacey Stein has authored 74 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Oncology, 24 papers in Pulmonary and Respiratory Medicine and 23 papers in Surgery. Recurrent topics in Stacey Stein's work include Colorectal Cancer Treatments and Studies (20 papers), Hepatocellular Carcinoma Treatment and Prognosis (19 papers) and Pancreatic and Hepatic Oncology Research (18 papers). Stacey Stein is often cited by papers focused on Colorectal Cancer Treatments and Studies (20 papers), Hepatocellular Carcinoma Treatment and Prognosis (19 papers) and Pancreatic and Hepatic Oncology Research (18 papers). Stacey Stein collaborates with scholars based in United States, Germany and South Korea. Stacey Stein's co-authors include Jill Lacy, Howard S. Höchster, Hyun S. Kim, Xiangyu Cong, Johannes Uhlig, Catherine Frenette, Marcia S. Brose, Stephen J. O’Keefe, Baek‐Yeol Ryoo and Xiaopan Yao and has published in prestigious journals such as Journal of Clinical Oncology, Molecular and Cellular Biology and Cancer.

In The Last Decade

Stacey Stein

74 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stacey Stein United States 18 802 387 355 327 315 74 1.4k
Roopinder Gillmore United Kingdom 15 684 0.9× 233 0.6× 367 1.0× 116 0.4× 176 0.6× 49 1.3k
Sebastian Leibl Austria 17 475 0.6× 194 0.5× 272 0.8× 225 0.7× 146 0.5× 29 1.3k
Dalila Sellami United States 17 411 0.5× 289 0.7× 421 1.2× 222 0.7× 549 1.7× 45 1.3k
Weikai Xiao China 18 477 0.6× 265 0.7× 213 0.6× 473 1.4× 425 1.3× 37 1.1k
Marlies Michl Germany 18 697 0.9× 384 1.0× 243 0.7× 193 0.6× 167 0.5× 47 1.1k
Martin Poleski United States 12 548 0.7× 192 0.5× 122 0.3× 193 0.6× 357 1.1× 18 1.2k
Ralph Wong Canada 5 1.3k 1.6× 400 1.0× 199 0.6× 325 1.0× 209 0.7× 8 1.5k
He Huang China 19 480 0.6× 159 0.4× 217 0.6× 297 0.9× 537 1.7× 78 1.4k
B. Mirtsching United States 12 1.1k 1.4× 459 1.2× 131 0.4× 288 0.9× 182 0.6× 27 1.3k
Zhenlin Yan China 20 697 0.9× 678 1.8× 714 2.0× 346 1.1× 237 0.8× 36 1.9k

Countries citing papers authored by Stacey Stein

Since Specialization
Citations

This map shows the geographic impact of Stacey Stein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stacey Stein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stacey Stein more than expected).

Fields of papers citing papers by Stacey Stein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stacey Stein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stacey Stein. The network helps show where Stacey Stein may publish in the future.

Co-authorship network of co-authors of Stacey Stein

This figure shows the co-authorship network connecting the top 25 collaborators of Stacey Stein. A scholar is included among the top collaborators of Stacey Stein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stacey Stein. Stacey Stein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Uhlig, Johannes, Joanna Gibson, Michael Cecchini, et al.. (2024). Epidemiology, treatment and outcomes of gastroenteropancreatic neuroendocrine neoplasms. Scientific Reports. 14(1). 30536–30536. 5 indexed citations
2.
Strazzabosco, Mario, Stacey Stein, Lynn Jeanette Savic, et al.. (2024). Tumor response assessment in hepatocellular carcinoma treated with immunotherapy: imaging biomarkers for clinical decision-making. European Radiology. 35(1). 73–83. 3 indexed citations
3.
Cecchini, Michael, Janie Y. Zhang, Wei Wei, et al.. (2023). Quantitative DNA Repair Biomarkers and Immune Profiling for Temozolomide and Olaparib in Metastatic Colorectal Cancer. Cancer Research Communications. 3(6). 1132–1139. 4 indexed citations
4.
Lacy, Jill, Michael Cecchini, Jeremy Kortmansky, et al.. (2023). Pre-operative chemoradiotherapy with or without induction chemotherapy for operable locally-advanced esophageal cancer. Journal of Gastrointestinal Oncology. 14(3). 1181–1192. 3 indexed citations
5.
Eng, Cathy, Emerson Y. Chen, Jane E. Rogers, et al.. (2021). Moving Beyond the Momentum: Innovative Approaches to Clinical Trial Implementation. JCO Oncology Practice. 17(10). 607–614. 6 indexed citations
6.
Patel, Timil, Joseph A. Miccio, Michael Cecchini, et al.. (2021). Clinical outcomes of first line FOLFIRINOX vs. gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer at the Yale Smilow Hospital System. Journal of Gastrointestinal Oncology. 12(6). 2547–2556. 3 indexed citations
7.
He, Aiwu Ruth, Kabir Mody, Kevin Kim, et al.. (2021). A phase II study of atezolizumab (ATEZO) and bevacizumab (Bev) in combination with Y90 TARE in patients (Pts) with hepatocellular carcinoma (HCC).. Journal of Clinical Oncology. 39(3_suppl). TPS358–TPS358. 4 indexed citations
8.
Goyal, Lipika, Cynthia A. Sirard, Michael Schrag, et al.. (2020). Phase I and Biomarker Study of the Wnt Pathway Modulator DKN-01 in Combination with Gemcitabine/Cisplatin in Advanced Biliary Tract Cancer. Clinical Cancer Research. 26(23). 6158–6167. 46 indexed citations
9.
Kim, Richard D., Shannon McDonough, Anthony B. El-Khoueiry, et al.. (2020). Randomised phase II trial (SWOG S1310) of single agent MEK inhibitor trametinib Versus 5-fluorouracil or capecitabine in refractory advanced biliary cancer. European Journal of Cancer. 130. 219–227. 26 indexed citations
10.
Stein, Stacey, et al.. (2020). Direct-Acting Antivirals Improve Overall Survival in Interventional Oncology Patients with Hepatitis C and Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology. 31(6). 953–960. 5 indexed citations
11.
Goff, Laura W., Nilofer S. Azad, Stacey Stein, et al.. (2018). Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancer. Investigational New Drugs. 37(2). 315–322. 13 indexed citations
12.
Pishvaian, Michael J., Baek‐Yeol Ryoo, Stacey Stein, et al.. (2018). Updated safety and clinical activity results from a phase Ib study of atezolizumab + bevacizumab in hepatocellular carcinoma (HCC). Annals of Oncology. 29. viii718–viii719. 62 indexed citations
13.
Blakaj, Adriana, Stacey Stein, Sajid Khan, & Kimberly L. Johung. (2018). Review and current state of radiation therapy for locally advanced pancreatic adenocarcinoma. Journal of Gastrointestinal Oncology. 9(6). 1027–1036. 10 indexed citations
14.
15.
Ryan, David P., Janet E. Murphy, Devalingam Mahalingam, et al.. (2016). PD-016 Current results of a phase I study of DKN-01 in combination with paclitaxel (P) in patients (pts) with advanced DKK1+ esophageal cancer (EC) or gastro-esophageal junction tumors (GEJ). Annals of Oncology. 27. ii108–ii108. 6 indexed citations
16.
Stein, Stacey, Edward James, Yanhong Deng, et al.. (2016). Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer. British Journal of Cancer. 114(7). 737–743. 153 indexed citations
17.
Stein, Stacey, Amy Tiersten, Howard S. Höchster, et al.. (2013). A Phase 2 Study of Oxaliplatin Combined With Continuous Infusion Topotecan for Patients With Previously Treated Ovarian Cancer. International Journal of Gynecological Cancer. 23(9). 1577–1582. 10 indexed citations
18.
Stein, Stacey. (2013). Hepatocellular Carcinoma. Journal of Clinical Gastroenterology. 47(Supplement 1). S47–S49. 12 indexed citations
19.
Gunturu, Krishna S., Xiaopan Yao, Xiangyu Cong, et al.. (2012). FOLFIRINOX for locally advanced and metastatic pancreatic cancer: single institution retrospective review of efficacy and toxicity. Medical Oncology. 30(1). 361–361. 115 indexed citations
20.
Stein, Stacey, Deirdre Jill Cohen, & Howard S. Höchster. (2010). Treatment Paradigms With Epidermal Growth Factor Receptor–Targeted Therapies in Colorectal Cancer. Clinical Colorectal Cancer. 9. S44–S50. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roopinder Gillmore Breakdown of academic impact, for papers by Sebastian Leibl Breakdown of academic impact, for papers by Dalila Sellami Breakdown of academic impact, for papers by Weikai Xiao Breakdown of academic impact, for papers by Marlies Michl Breakdown of academic impact, for papers by Martin Poleski Breakdown of academic impact, for papers by Ralph Wong Breakdown of academic impact, for papers by He Huang Breakdown of academic impact, for papers by B. Mirtsching Breakdown of academic impact, for papers by Zhenlin Yan
Rankless by CCL
2026